|
|
Article: MicroPhage Demonstrates Rapid Diagnostic Platform Feasibility in Skin and Soft Tissue Infections.
- Article from:
- Biotech Week
- Article date:
- June 3, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
In a presentation at the current General Meeting of the American Society for Microbiology (ASM) being held in Philadelphia, PA, a simple and inexpensive developmental diagnostic assay produced by MicroPhage, Inc., www.microphage.com, was shown to be highly accurate for rapid identification of serious staph bacterial infections from skin and soft tissue infections (see also MicroPhage, Inc.).
Thirty three samples from a wide array of body sites were collected from the St. Mary-Corwin Hospital in Pueblo Colorado. Of the 33, 8 were determined to have Staphylococcus aureus infections by traditional microbiology methods. Seven of these samples were rapidly detected by ...
Related newspaper, magazine, and journal articles:
|
|
Article: MicroPhage, Inc. Raises Additional Funding to Respond to ...
Business Wire;
October 17, 2007 ;
700+ words
... ... contracting it from inside their facilities. MicroPhage, Inc., an early stage medical diagnostics ... to other hospitalized patients. The MicroPhage test uses bacteriophages, the natural ... replicate. It is this replication that MicroPhage uses to determine MRSA quickly and efficiently ...
|
|